Back to Search Start Over

Increased mucosal thrombin is associated with Crohn's disease and causes inflammatory damage through Protease-Activated Receptors activation

Authors :
Motta, Jean-Paul
Palese, Simone
Giorgio, Carmine
Chapman, Kevin
Denadai-Souza, Alexandre
Rousset, Perrine
Sagnat, David
Guiraud, Laura
Edir, Anissa
Seguy, Carine
Alric, Laurent
Bonnet, Delphine
Bournet, Barbara
Buscail, Louis
Gilletta, Cyrielle
Buret, Andre
Wallace, John
Hollenberg, Morley
Oswald, Eric
Barocelli, Elisabetta
Le Grand, Sylvie
Le Grand, Bruno
Deraison, Céline
Vergnolle, Nathalie
Institut de Recherche en Santé Digestive (IRSD )
Université Toulouse III - Paul Sabatier (UT3)
Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Ecole Nationale Vétérinaire de Toulouse (ENVT)
Institut National Polytechnique (Toulouse) (Toulouse INP)
Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National Polytechnique (Toulouse) (Toulouse INP)
Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)
CVasThera
University of Parma
University of Calgary
CHU Toulouse [Toulouse]
Université Fédérale Toulouse Midi-Pyrénées
Occitanie region grant ('contrat innovation' reference: DEI-SYNAPSE)
MICILIP project (NCT01990716)
cellular imaging facility TRI-CPTP
COLIC collection (DC-2015-2443)
Alberta-Innovate Health Services (AIHS)
FEDER funding (EU and Occitanie region: Nanorgan project)
Antibe Therapeutics
UMS 006 (animal care facility, histopathology core facility)
ANR-11-EQPX-0003,ANINFIMIP,Equipements plateforme animalerie infectieuse de haute-sécurité de Midi Pyrénées(2011)
European Project: 310973,EC:FP7:ERC,ERC-2012-StG_20111109,PIPE(2013)
European Project: 609398,EC:FP7:PEOPLE,FP7-PEOPLE-2013-COFUND,AGREENSKILLSPLUS(2014)
University of Parma = Università degli studi di Parma [Parme, Italie]
SEGUIN, Nathalie
Equipements plateforme animalerie infectieuse de haute-sécurité de Midi Pyrénées - - ANINFIMIP2011 - ANR-11-EQPX-0003 - EQPX - VALID
Physiology of the Intestine: Proteases from the Epithelium - PIPE - - EC:FP7:ERC2013-04-01 - 2018-03-31 - 310973 - VALID
AgreenSkills+ - AGREENSKILLSPLUS - - EC:FP7:PEOPLE2014-05-05 - 2019-05-04 - 609398 - VALID
Università degli studi di Parma = University of Parma (UNIPR)
Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)
Université de Toulouse (UT)-Université de Toulouse (UT)-Ecole Nationale Vétérinaire de Toulouse (ENVT)
Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National Polytechnique (Toulouse) (Toulouse INP)
Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)
Université de Toulouse (UT)
Source :
Journal of Crohn's and Colitis, Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2020, ⟨10.1093/ecco-jcc/jjaa229⟩, Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2021, 15 (5), pp.787-799. ⟨10.1093/ecco-jcc/jjaa229⟩, Journal of Crohn's & Colitis, Journal of Crohn's and Colitis, 2021, 15 (5), pp.787-799. ⟨10.1093/ecco-jcc/jjaa229⟩
Publication Year :
2020
Publisher :
HAL CCSD, 2020.

Abstract

BACKGROUND AND AIMS: Thrombin levels in the colon of Crohn's disease patients have recently been found to be elevated 100-fold compared with healthy controls. Our aim was to determine whether and how dysregulated thrombin activity could contribute to local tissue malfunctions associated with Crohn's disease. METHODS: Thrombin activity was studied in tissues from Crohn's disease patients and healthy controls. Intracolonic administration of thrombin to wild-type or protease-activated receptor-deficient mice was used to assess the effects and mechanisms of local thrombin upregulation. Colitis was induced in rats and mice by the intracolonic administration of trinitrobenzene sulphonic acid. RESULTS: Active forms of thrombin were increased in Crohn's disease patient tissues. Elevated thrombin expression and activity were associated with intestinal epithelial cells. Increased thrombin activity and expression were also a feature of experimental colitis in rats. Colonic exposure to doses of active thrombin comparable to what is found in inflammatory bowel disease tissues caused mucosal damage and tissue dysfunctions in mice, through a mechanism involving both protease-activated receptors -1 and -4. Intracolonic administration of the thrombin inhibitor dabigatran, as well as inhibition of protease-activated receptor-1, prevented trinitrobenzene sulphonic acid-induced colitis in rodent models. CONCLUSIONS: Our data demonstrated that increased local thrombin activity, as it occurs in the colon of patients with inflammatory bowel disease, causes mucosal damage and inflammation. Colonic thrombin and protease-activated receptor-1 appear as possible mechanisms involved in mucosal damage and loss of function and therefore represent potential therapeutic targets for treating inflammatory bowel disease. ispartof: JOURNAL OF CROHNS & COLITIS vol:15 issue:5 pages:787-799 ispartof: location:England status: published

Details

Language :
English
ISSN :
18739946 and 18764479
Database :
OpenAIRE
Journal :
Journal of Crohn's and Colitis, Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2020, ⟨10.1093/ecco-jcc/jjaa229⟩, Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2021, 15 (5), pp.787-799. ⟨10.1093/ecco-jcc/jjaa229⟩, Journal of Crohn's & Colitis, Journal of Crohn's and Colitis, 2021, 15 (5), pp.787-799. ⟨10.1093/ecco-jcc/jjaa229⟩
Accession number :
edsair.pmid.dedup....6e9d26bcf7ad11794fa76d2f02c48061